CytomX Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CTMX Nasdaq 2830 www.cytomx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CytomX Therapeutics, Inc.

Allogene's Q4 Loss Narrower Than Expected, Revenues Nil - Mar 14th, 2025 11:52 am
CytomX Therapeutics (CTMX) Upgraded to Strong Buy: Here's What You Should Know - Mar 11th, 2025 4:00 pm
CytomX Therapeutics Full Year 2024 Earnings: Beats Expectations - Mar 8th, 2025 12:10 pm
CytomX Therapeutics, Inc. (CTMX): Among the Cheap Growth Stocks to Buy Now - Mar 7th, 2025 11:45 pm
Q4 2024 CytomX Therapeutics Inc Earnings Call - Mar 7th, 2025 12:41 pm
CytomX Therapeutics Inc (CTMX) Q4 2024 Earnings Call Highlights: Strategic Advances and ... - Mar 7th, 2025 7:18 am
CytomX Therapeutics (CTMX) Tops Q4 Earnings and Revenue Estimates - Mar 6th, 2025 10:35 pm
CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update - Mar 6th, 2025 9:10 pm
CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference - Mar 5th, 2025 1:00 pm
CytomX Gears Up to Report Q4 Earnings: What Should Investors Expect? - Mar 4th, 2025 2:42 pm
CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Feb 27th, 2025 1:00 pm
Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago - Jan 29th, 2025 2:21 pm
AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer - Jan 20th, 2025 7:05 pm
PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales - Jan 13th, 2025 4:43 pm
CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 8th, 2025 1:00 pm
All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy - Jan 7th, 2025 5:00 pm
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update - Jan 6th, 2025 9:05 pm
KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates - Jan 6th, 2025 1:59 pm
Here's Why Arcutis Stock More Than Doubled in Market Value in One Year - Jan 3rd, 2025 6:28 pm
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug - Jan 3rd, 2025 3:56 pm